• cholesterol
  • In our previous studies, we showed that the intestinal cholesterol transporter inhibitor, ezetimibe, attenuates PHTG and postprandial elevation of FFAs in patients with type IIb hyperlipidemia (Eur J Clin Invest 2009), however the mechanisms for this have not been elucidated yet. (ahajournals.org)
  • role of each of them is strictly defined and is directly opposed to the mechanism of lipid metabolism (HDL and LDL), the rate of these indicators, respectively up to 1.05 mmol / L and 4.5 mmol / L.In addition, fractions of cholesterol and triglycerides are.All these components are defined in the study entitled lipidogram.This biochemical analysis quantified the total cholesterol, LDL, HDL and triglycerides. (healthtipsing.com)